Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall (DIGNITY)

This study is currently recruiting participants.
Verified October 2013 by Celsion
Sponsor:
Information provided by (Responsible Party):
Celsion
ClinicalTrials.gov Identifier:
NCT00826085
First received: January 19, 2009
Last updated: October 21, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2014
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)